Skip to main content

Schmertzler Michael

In the past year, 4 open-market sale filings worth $6.31M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$6.31M
4 filings
Net
−$6.31M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Schmertzler Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PTCT PTC Therapeutics, Inc.

Director6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 9, 2023 (view filing)Jun 72 daysSchmertzler MichaelDirectorSSale−1.00K$44.86−$44.9K−0.8%116.8K after10b5-1
Jan 10, 2024 (view filing)Jan 82 daysSchmertzler MichaelDirectorSSale−1.50K$27.81−$41.7K−1.3%115.3K after10b5-1
Aug 21, 2026 (view filing)5:20 PM ETAug 19-202 daysSchmertzler MichaelDirectorSSale−25.0K$72.22−$1.81M−1.8%1.36M after5 lots10b5-1
Aug 28, 2026 (view filing)5:20 PM ETAug 26-272 daysSchmertzler MichaelDirectorSSale−25.0K$72.26−$1.81M−1.8%1.34M after4 lots10b5-1
Sep 11, 2026 (view filing)5:20 PM ETSep 9-102 daysSchmertzler MichaelDirectorSSale−20.0K$67.59−$1.35M−1.5%1.32M after3 lots10b5-1
Sep 18, 2026 (view filing)5:20 PM ETSep 16-172 daysSchmertzler MichaelDirectorSSale−20.0K$67.49−$1.35M−1.5%1.30M after4 lots10b5-1